PaperPanda Equity Terminal
PTGX —
PROTAGONIST THERAPEUTICS INC
CUSIP: 74366E102 · Held by 4 superinvestors · Combined value: $123,158,198
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $106,719,610 | 1,221,887 | ADD | +952,606 |
| 2 | Stanley Druckenmiller | 0.3% | $13,948,000 | 159,700 | - | - |
| 3 | Polen Capital | 0.0% | $1,777,282 | 20,349 | ADD | +24 |
| 4 | Jim Simons | 0.0% | $713,306 | 8,167 | NEW BUY | +8,167 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | NEW BUY | +8,167 | New |
| Ken Griffin | ADD | +952,606 | +353.8% |
| Polen Capital | ADD | +24 | +0.1% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Stanley Druckenmiller | NEW BUY | +159,700 | New |
| Ken Griffin | ADD | +211,580 | +366.7% |
| Polen Capital | ADD | +4,326 | +27.0% |
| Jim Simons | SOLD | -173,134 | Exit |
Who Owns PTGX? Superinvestor Holdings
PROTAGONIST THERAPEUTICS INC is held by 4 tracked superinvestors, with a combined position value of $123 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Stanley Druckenmiller (0.3% of portfolio), Polen Capital (0.0% of portfolio).
In the most recent quarter, 3 superinvestors added or initiated positions.